Biotech Stocks Move Higher: IMNN Surges Over 18%, HSCS Gains Over 13%, SXTC Rises 7%

Biotech equities rallied in the session, with Imunon (IMNN) rising more than 18%, HSCS gaining over 13%, and SXTC advancing 7%, according to the Nasdaq report. The moves point to small-cap biotech as the primary driver, as these names typically exhibit high beta and react sharply to company-specific news, sector sentiment, and shifts in risk appetite toward speculative growth. Because the gains are concentrated in small-cap biotech rather than the broad index, the transmission runs through speculative risk-taking and funding conditions for clinical-stage companies, which are sensitive to changes in real rate expectations and the cost of capital. The Nasdaq-100 (NDX) and its technology-heavy constituents are less directly exposed, so any spillover to large-cap tech would likely depend on whether the rally broadens into a wider risk-on move. Traders should watch the next Federal Reserve rate-path signals and Treasury yield moves, since a decline in yields typically supports small-cap biotech valuations and financing access.

The Nasdaq-100 (NDX) is the US large-cap tech benchmark. NDX is more sensitive to rate decisions than SPX because of longer-duration cash flows, and heavily concentrated in Tech/Comms names — mega-cap earnings season dominates price action.

HIGH-impact news is typically a market-moving event with multi-pip or multi-percent intraday reactions. Examples include central bank rate decisions, major CPI/NFP releases, geopolitical shocks, mega-cap earnings beats/misses, and regulatory announcements. Traders typically position-reduce or hedge ahead of scheduled HIGH-impact events, and follow the wire in real time to react to unscheduled ones (war headlines, central-bank emergency statements, surprise corporate actions). The Trading News Terminal squawk box reads every HIGH-impact headline aloud the moment it hits the wire — so active traders don't have to stare at the feed.

Active traders typically follow a three-step workflow when a market-moving headline hits the wire: (1) read the headline on the terminal or hear it on the squawk box; (2) assess whether the news is already priced in (by checking intraday price action in the seconds before) or whether it's genuinely new information; (3) act — either entering a breakout position, fading an overreaction, or tightening stops on existing trades. Trading News Terminal's Pro plan delivers wire-grade headlines within seconds of the source, with automatic audio squawk on every HIGH-impact event, so the read-assess-act cycle never waits on a refresh button.